Alkem Lab

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE540L01014
NSEID: ALKEM
BSEID: 539523
View on NSE | View on BSE

INR

5,284.50

43.7 (0.83%)

BSENSE

Mar 20

BSE+NSE Vol: 3.27 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lupin

Glenmark Pharma

Laurus Labs

Aurobindo Pharma

Biocon

Zydus Lifesci.

Alkem Lab

Abbott India

Glaxosmi. Pharma

Mankind Pharma

Cipla

Why is Alkem Laboratories Ltd ?

Poor long term growth as Operating profit has grown by an annual rate 8.21% of over the last 5 years

Flat results in Dec 25

CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 1,547.65 cr
DEBTORS TURNOVER RATIO(HY) Lowest at 4.49 times

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alkem Lab for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Alkem Lab

7.92%

0.35

22.94%

Sensex

-2.38%

-0.19

12.70%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.29%

EBIT Growth (5y)

8.21%

EBIT to Interest (avg)

20.79

Debt to EBITDA (avg)

0.85

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

1.00

Tax Ratio

14.76%

Dividend Payout Ratio

24.84%

Pledged Shares

Institutional Holding

31.51%

ROCE (avg)

20.14%

ROE (avg)

16.90%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.73

EV to EBIT

25.12

EV to EBITDA

21.72

EV to Capital Employed

4.92

EV to Sales

4.39

PEG Ratio

2.36

Dividend Yield

0.97%

ROCE (Latest)

19.13%

ROE (Latest)

17.61%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-3What is not working for the Company

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 1,547.65 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.49 times

Loading Valuation Snapshot...

Here's what is not working for Alkem Lab

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 1,547.65 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly

Lowest at 4.49 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio